Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1994 1
2003 1
2005 1
2007 1
2009 1
2011 1
2013 1
2014 2
2015 8
2016 6
2017 9
2018 6
2019 6
2020 9
2021 15
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.
Gilotra NA, Griffin JM, Pavlovic N, Houston BA, Chasler J, Goetz C, Chrispin J, Sharp M, Kasper EK, Chen ES, Blankstein R, Cooper LT, Joyce E, Sheikh FH. Gilotra NA, et al. J Card Fail. 2022 Jan;28(1):113-132. doi: 10.1016/j.cardfail.2021.06.016. Epub 2021 Jul 11. J Card Fail. 2022. PMID: 34260889 Free PMC article. Review.
The prevalence of sarcoidosis-related cardiomyopathy is increasing. Sarcoidosis impacts cardiac function through granulomatous infiltration of the heart, resulting in conduction disease, arrhythmia, and/or heart failure. ...Patients may progress to developing …
The prevalence of sarcoidosis-related cardiomyopathy is increasing. Sarcoidosis impacts cardiac function through granulomatous infilt …
Echocardiography in Sarcoidosis.
Kurmann R, Mankad SV, Mankad R. Kurmann R, et al. Curr Cardiol Rep. 2018 Sep 26;20(11):118. doi: 10.1007/s11886-018-1065-9. Curr Cardiol Rep. 2018. PMID: 30259211 Review.
PURPOSE OF REVIEW: Cardiac sarcoidosis (CS) is associated with significant morbidity and mortality. ...Cardiac sarcoidosis remains a difficult condition to diagnose. However early diagnosis is critical to decrease the associated high mortality. ...
PURPOSE OF REVIEW: Cardiac sarcoidosis (CS) is associated with significant morbidity and mortality. ...Cardiac sarcoidosis rem …
Update on cardiac sarcoidosis.
Tan JL, Tan BE, Cheung JW, Ortman M, Lee JZ. Tan JL, et al. Trends Cardiovasc Med. 2023 Oct;33(7):442-455. doi: 10.1016/j.tcm.2022.04.007. Epub 2022 Apr 30. Trends Cardiovasc Med. 2023. PMID: 35504422 Review.
It is characterized by the deposition of non-caseating granulomas that may involve any part of the heart. Cardiac sarcoidosis is often under-diagnosed or recognized partly due to the heterogeneous clinical presentation of the disease. The three most frequent clinica …
It is characterized by the deposition of non-caseating granulomas that may involve any part of the heart. Cardiac sarcoidosis …
Imaging and Quantification of Cardiac Sarcoidosis.
Elwazir MY, Bois JP, Abou Ezzeddine OF, Chareonthaitawee P. Elwazir MY, et al. Semin Nucl Med. 2020 Jul;50(4):283-294. doi: 10.1053/j.semnuclmed.2020.03.005. Epub 2020 Apr 25. Semin Nucl Med. 2020. PMID: 32540026 Review.
Cardiac sarcoidosis (CS) refers to the increasingly recognized cardiac involvement of an incompletely understood systemic disease entity-sarcoidosis. ...Within the last few years, societal documents have included advanced cardiovascular imaging modalities, (18)F-FDG
Cardiac sarcoidosis (CS) refers to the increasingly recognized cardiac involvement of an incompletely understood systemic dise
Patient page-sarcoidosis imaging.
Bois JP, Chareonthaitawee P. Bois JP, et al. J Nucl Cardiol. 2019 Feb;26(1):222-226. doi: 10.1007/s12350-017-1100-z. Epub 2017 Nov 1. J Nucl Cardiol. 2019. PMID: 29094295 Review.
Optimizing our imaging capabilities for patients with cardiac sarcoidosis is critical as it has diagnostic, prognostic, and therapeutic implications. (18)FDG PET/CT has the highest sensitivity for the detection of CS but requires specific dietary preparation that is diffic …
Optimizing our imaging capabilities for patients with cardiac sarcoidosis is critical as it has diagnostic, prognostic, and therapeut …
Utilization of cardiac imaging in sarcoidosis.
Elwazir MY, Bois JP, Chareonthaitawee P. Elwazir MY, et al. Expert Rev Cardiovasc Ther. 2022 Apr;20(4):253-266. doi: 10.1080/14779072.2022.2069560. Epub 2022 May 1. Expert Rev Cardiovasc Ther. 2022. PMID: 35469519 Review.
INTRODUCTION: Cardiac sarcoidosis (CS) is the cardiac, and occasionally the only manifestation, of a systemic disease of unknown etiology inherently challenging to definitively diagnose due to the lack of a reliable gold standard, the current being endomyocardial bi …
INTRODUCTION: Cardiac sarcoidosis (CS) is the cardiac, and occasionally the only manifestation, of a systemic disease of unkno …
PET/CT Evaluation of Cardiac Sarcoidosis.
Bois JP, Muser D, Chareonthaitawee P. Bois JP, et al. PET Clin. 2019 Apr;14(2):223-232. doi: 10.1016/j.cpet.2018.12.004. Epub 2019 Feb 1. PET Clin. 2019. PMID: 30826020 Review.
The increasing implementation of advanced cardiovascular imaging in the form of cardiac PET/CT has had a significant impact on the management of cardiac sarcoidosis, which continues to evolve. ...
The increasing implementation of advanced cardiovascular imaging in the form of cardiac PET/CT has had a significant impact on the ma …
Imaging cardiac sarcoidosis and infiltrative diseases: diagnosis and therapeutic response.
Elwazir MY, Bois JP, Abouezzeddine OF, Chareonthaitawee P. Elwazir MY, et al. Q J Nucl Med Mol Imaging. 2020 Mar;64(1):51-73. doi: 10.23736/S1824-4785.20.03235-5. Epub 2020 Jan 24. Q J Nucl Med Mol Imaging. 2020. PMID: 31992689 Free article. Review.
While cardiac involvement may be detected by echocardiography, other imaging modalities such as cardiac magnetic resonance, single-photon emission computed tomography, or positron emission tomography provide additional critical diagnostic, prognostic and therapeutic …
While cardiac involvement may be detected by echocardiography, other imaging modalities such as cardiac magnetic resonance, si …
Cardiac resynchronization therapy response in cardiac sarcoidosis.
Shabtaie SA, Sehrawat O, Lee JZ, Cha YM, Mulpuru SK, Kowlgi NG, Siontis KC, Rosenbaum AN, Bois JP, AbouEzzeddine OF, Noseworthy PA, Asirvatham SJ, DeSimone CV, Deshmukh AJ. Shabtaie SA, et al. J Cardiovasc Electrophysiol. 2022 Sep;33(9):2072-2080. doi: 10.1111/jce.15631. Epub 2022 Aug 4. J Cardiovasc Electrophysiol. 2022. PMID: 35870183
INTRODUCTION: Cardiac sarcoidosis (CS) is a nonischemic cardiomyopathy (NICM) characterized by infiltration of noncaseating granulomas involving the heart with highly variable clinical manifestations that can include conduction abnormalities and systolic heart
INTRODUCTION: Cardiac sarcoidosis (CS) is a nonischemic cardiomyopathy (NICM) characterized by infiltration of noncaseating granuloma …
80 results